Alli hits European stores
This article was originally published in The Tan Sheet
Executive Summary
Pharmacies across Europe now sell GlaxoSmithKline's non-prescription weight-loss drug alli (orlistat 60 mg), the firm says April 20. The European Commission, in its first centralized Rx-to-OTC switch process, approved the product for non-Rx sale to adults with a body mass index of 28 kg/m2 or more in all 27 EU member countries (1"The Tan Sheet" Jan. 26, 2009, In Brief)
|
Pharmacies across Europe now sell GlaxoSmithKline's non-prescription weight-loss drug alli (orlistat 60 mg), the firm says April 20. The European Commission, in its first centralized Rx-to-OTC switch process, approved the product for non-Rx sale to adults with a body mass index of 28 kg/m2 or more in all 27 EU member countries (1 'The Tan Sheet' Jan. 26, 2009, In Brief). |